Los Angeles Capital Management & Equity Research Inc. cut its stake in Healthways Inc. (NASDAQ:HWAY) by 9.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 24,179 shares of the company’s stock after selling 2,625 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.07% of Healthways worth $279,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of HWAY. Quantitative Systematic Strategies LLC purchased a new position in shares of Healthways during the second quarter valued at about $118,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its position in Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock valued at $135,000 after buying an additional 825 shares during the last quarter. KBC Group NV bought a new position in Healthways during the second quarter valued at $147,000. Magnetar Financial LLC bought a new position in Healthways during the first quarter valued at $140,000. Finally, Arizona State Retirement System boosted its position in Healthways by 7.3% in the first quarter. Arizona State Retirement System now owns 16,083 shares of the company’s stock valued at $162,000 after buying an additional 1,100 shares during the last quarter. 92.52% of the stock is owned by institutional investors and hedge funds.
Shares of Healthways Inc. (NASDAQ:HWAY) traded down 0.34% during mid-day trading on Thursday, reaching $26.24. 425,812 shares of the company traded hands. The firm’s market capitalization is $964.01 million. Healthways Inc. has a 52 week low of $9.18 and a 52 week high of $27.30. The firm has a 50-day moving average price of $24.85 and a 200 day moving average price of $15.26.
Healthways (NASDAQ:HWAY) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.53. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The business had revenue of $125 million for the quarter, compared to analysts’ expectations of $186.88 million. During the same period last year, the business earned $0.11 EPS. The company’s revenue was up 10.2% compared to the same quarter last year. On average, analysts anticipate that Healthways Inc. will post $2.11 earnings per share for the current year.
Several research firms have recently weighed in on HWAY. Zacks Investment Research cut shares of Healthways from a “buy” rating to a “hold” rating in a report on Tuesday, September 20th. Barclays PLC raised shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $12.00 to $27.00 in a report on Monday, August 22nd. Jefferies Group set a $26.00 price objective on shares of Healthways and gave the company a “hold” rating in a report on Thursday, August 18th. Oppenheimer Holdings Inc. raised shares of Healthways to an “outperform” rating and set a $27.00 price objective for the company in a report on Sunday, August 14th. Finally, FBR & Co boosted their price objective on shares of Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, August 10th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $24.21.
In other news, Director Mary Jane England sold 3,816 shares of the firm’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the sale, the director now directly owns 39,068 shares in the company, valued at approximately $968,105.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.01% of the stock is currently owned by insiders.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Want to see what other hedge funds are holding HWAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthways Inc. (NASDAQ:HWAY).
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.